tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Financial Statements

Compare
0 Followers

SynAct Pharma AB Financial Overview

SynAct Pharma AB's market cap is currently €75.14M. The company's EPS TTM is €-0.046580044; its P/E ratio is ―; SynAct Pharma AB is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr 0.00kr -778.00Kkr -1.06Mkr -88.00Kkr 0.00
Operating Incomekr -89.98Mkr -224.50Mkr -105.70Mkr -76.70Mkr -31.29M
EBITDAkr -15.40Mkr -222.70Mkr -105.71Mkr -76.62Mkr -30.90M
Net Incomekr -82.40Mkr -215.81Mkr -99.20Mkr -69.30Mkr -26.55M
Balance Sheet
Cash & Short-Term Investmentskr 61.21Mkr 62.40Mkr 108.25Mkr 24.00Mkr 14.55M
Total Assetskr 270.52Mkr 228.02Mkr 142.60Mkr 38.37Mkr 21.59M
Total Debtkr 1.88Mkr 637.00Kkr 2.06Mkr 3.09Mkr 0.00
Net Debtkr -59.33Mkr -61.76Mkr -106.18Mkr -20.91Mkr -14.55M
Total Liabilitieskr 56.35Mkr 51.83Mkr 16.08Mkr 17.50Mkr 5.72M
Stockholders' Equitykr 214.17Mkr 176.19Mkr 126.52Mkr 20.87Mkr 15.87M
Cash Flow
Free Cash Flowkr -89.20Mkr -100.18Mkr -117.56Mkr -65.00Mkr -33.24M
Operating Cash Flowkr -89.20Mkr -100.18Mkr -117.56Mkr -65.00Mkr -33.24M
Investing Cash Flowkr 0.00kr 370.00Kkr 27.00Kkr -6.00Kkr -93.00K
Financing Cash Flowkr 87.41Mkr 53.98Mkr 200.71Mkr 74.32Mkr 44.72M
Currency in SEK

SynAct Pharma AB Earnings and Revenue History

SynAct Pharma AB Debt to Assets

SynAct Pharma AB Cash Flow

SynAct Pharma AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis